CIK: 1714982 - Address: C/O Fulcrum Therapeutics, Inc., 26 Landsdowne Street, Cambridge, MA 02139
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

6/29/21 16:16
6/28/21
FULCFulcrum Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsOltmans Curtis GaleMAOSVP,GCP109.0101New1D
2/7/19 16:30
1/29/19
ARRYArray Biopharma IncDEHealthDrugPharmaceutical PreparationsOltmans Curtis GaleCOOGCM.dm4578.9405115D
2/7/19 16:30
2/5/19
ARRYArray Biopharma IncDEHealthDrugPharmaceutical PreparationsOltmans Curtis GaleCOOGCS.d-80020.000-40-7315D
1/29/19 16:27
1/25/19
ARRYArray Biopharma IncDEHealthDrugPharmaceutical PreparationsOltmans Curtis GaleCOOGCM.d1258.940144D
1/29/19 16:27
1/25/19
ARRYArray Biopharma IncDEHealthDrugPharmaceutical PreparationsOltmans Curtis GaleCOOGCS.d-25318.000-14-784D
1/23/19 16:47
1/18/19
ARRYArray Biopharma IncDEHealthDrugPharmaceutical PreparationsOltmans Curtis GaleCOOGCM.d118.9401474D
1/23/19 16:47
1/18/19
ARRYArray Biopharma IncDEHealthDrugPharmaceutical PreparationsOltmans Curtis GaleCOOGCS.d-2318.000-1-244D
1/17/19 16:58
1/15/19
ARRYArray Biopharma IncDEHealthDrugPharmaceutical PreparationsOltmans Curtis GaleCOOGCM.d1768.940204D
1/17/19 16:58
1/15/19
ARRYArray Biopharma IncDEHealthDrugPharmaceutical PreparationsOltmans Curtis GaleCOOGCS.d-35618.060-20-834D
12/18/18 19:48
12/16/18
ARRYArray Biopharma IncDEHealthDrugPharmaceutical PreparationsOltmans Curtis GaleCOOGCM.d00.00074D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact